⌘K

Login Start Free

Home/Filings/4/0001209191-18-060006

4//SEC Filing

Levy Howard 4

Accession 0001209191-18-060006

CIK 0001124105other

View on SEC.gov Company Profile

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 5:01 PM ET

Size

6.9 KB

Accession

0001209191-18-060006

Insider Transaction Report

Form 4

Period: 2018-11-26

CATALYST BIOSCIENCES, INC.CBIO

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2018-11-26$4.63/sh+149$690→ 7,709 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-11-26−149→ 87,118 total
Exercise: $4.63Exp: 2027-07-11→ Common Stock (149 underlying)

Footnotes (1)

[F1]The Option vests monthly over a period of four years commencing June 15, 2017.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeother

Related Parties

1

filerCIK 0001672333

Filing Metadata

Form type: 4
Filed: Nov 26, 7:00 PM ET
Accepted: Nov 27, 5:01 PM ET
Size: 6.9 KB

View on SEC.gov